WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Exenatide

Governed registry record

5 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Open the peptide evidence profile →

Approved source records

  1. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

    DOI: 10.1056/nejmoa1612917PMID: 28910237

    Source identity and connection checked by Codex (AI).

  2. Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.

    DOI: 10.2337/dc17-0417PMID: 29246950

    Source identity and connection checked by Codex (AI).

  3. Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial.

    DOI: 10.1172/jci.insight.159863PMID: 36066977

    Source identity and connection checked by Codex (AI).

  4. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

    DOI: 10.1016/s0140-6736(17)31585-4PMID: 28781108

    Source identity and connection checked by Codex (AI).

  5. Exenatide.

    DOI: 10.1517/14656566.8.15.2593PMID: 17931093

    Source identity and connection checked by Codex (AI).